Session Details

S036 Hair Disorders Made Easier

Sat, Mar 9, 1:00 PM - 4:00 PM
Room 20B
3 CME Available Symposium
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

This session will present a practical approach to hair disorders focused on the key differential diagnosis and types of therapy.

LEARNING OBJECTIVES

1.

Evaluate scarring alopecia

2.

Evaluate nonscarring alopecia

3.

Treat scarring alopecia

SCHEDULE

9:00 PM

Getting the most from your alopecia pathology reports

Lynne J. Goldberg, MD, FAAD

9:20 PM

Diagnosis of non-scarring hair loss by trichoscopy

Rodrigo Pirmez, MD

9:45 PM

Tips on evaluation and diagnosis of scarring alopecia

Melissa Piliang, MD, FAAD

10:10 PM

Treatment and follow-up of non-scarring alopecia

Jerry Shapiro, MD, FAAD

10:35 PM

Pearls in the management of scarring alopecia

Maryanne Makredes Senna, MD, FAAD

11:00 PM

Styling tricks and helpful tips for ethnic hair loss

Yolanda M Lenzy, MD, FAAD

11:25 PM

Surgical and alternative treatments for alopecia

Meena Kumari Singh, MD, FAAD

11:50 PM

Questions and Answers

SPEAKERS

Lynne J. Goldberg, MD, FAAD

Lynne J. Goldberg, MD, FAAD

Yolanda M Lenzy, MD, FAAD

Yolanda M Lenzy, MD, FAAD

Maryanne Makredes Senna, MD, FAAD

Maryanne Makredes Senna, MD, FAAD

Melissa Piliang, MD, FAAD

Melissa Piliang, MD, FAAD

Rodrigo Pirmez, MD

Rodrigo Pirmez, MD

Jerry Shapiro, MD, FAAD

Jerry Shapiro, MD, FAAD

Meena Kumari Singh, MD, FAAD

Meena Kumari Singh, MD, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Lynne J. Goldberg, MD, FAAD

UpToDate, Inc – Other(Fees);

Yolanda M Lenzy, MD, FAAD

CeraVe/Valeante – Other(Fees);

Maryanne Makredes Senna, MD, FAAD

AbbVie – Advisory Board(Fees); American Hair Research Society – Board of Directors(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Fees); Cassiopia – Advisory Board(Fees); Cicatricial Alopecia Research Foundation – Board of Directors(No Compensation Received); Concert Pharmaceuticals – Consultant(Fees); Department Of Health and Human Services; Division of Vaccine Injury Compensation – Independent Contractor(Fees); Eli Lilly – Speaker(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Follica – Investigator(Equipment); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Kintor Pharmaceutical Limited – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Fees), Other(Grants/Research Funding), Speaker(Fees); Santiste Medical – Investigator(Grants/Research Funding);

Melissa Piliang, MD, FAAD

Eli Lilly and Company – Investigator(No Compensation Received), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(No Compensation Received); Procter & Gamble Company – Consultant(Honoraria);

Rodrigo Pirmez, MD

Ache Laboratório Farmaceuticso S.A. – Consultant(Fees); Darrow – Consultant(Fees); Eli Lilly and Company – Consultant(Fees); GlaxoSmithKline Immunology – Speaker(Fees); Pfizer Inc. – Consultant(Fees); Vichy Laboratoires – Speaker(Fees);

Jerry Shapiro, MD, FAAD

30 Madison – Consultant (1099 relationship)(Stock Options); Almirall – Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria);

Meena Kumari Singh, MD, FAAD

Eli Lilly – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant (1099 relationship)(Fees);